SAN DIEGO – KYinno Biotechnology left an indelible mark with its robust participation and sponsorship at the 22nd San Diego BioPharma Conference on September 30th.
The event, a nexus of academia and industry, highlighted significant biopharmaceutical advancements. The discussions spanned from protein misfolding and cancer innovations to new-age CART and antibody therapies. An in-depth look into a successful acquisition and unveiling of novel therapeutic platforms were particularly noteworthy. More insights are available at www.sabpa.org.
During a pivotal panel discussion, KYinno Biotechnology joined industry leaders in dissecting the challenges and opportunities for biotech entrepreneurs, emphasizing San Diego’s evolving biotech arena.
Furthermore, KYinno Biotechnology is set to continue its engagement with the upcoming 2024 SABPA annual FTD Forum on March 23, 2024.
KYinno’s consistent involvement underscores its dedication to biotech innovation and industry progression.